846 related articles for article (PubMed ID: 36367225)
1. m6A readers, writers, erasers, and the m6A epitranscriptome in breast cancer.
Petri BJ; Klinge CM
J Mol Endocrinol; 2023 Feb; 70(2):. PubMed ID: 36367225
[TBL] [Abstract][Full Text] [Related]
2. RNA m6A modification, signals for degradation or stabilisation?
Wei G
Biochem Soc Trans; 2024 Apr; 52(2):707-717. PubMed ID: 38629637
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Analysis of N6-Methyladenosine (m6A) Writers, Erasers, and Readers in Cervical Cancer.
Condic M; Ralser DJ; Klümper N; Ellinger J; Qureischi M; Egger EK; Kristiansen G; Mustea A; Thiesler T
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806168
[TBL] [Abstract][Full Text] [Related]
4. Research advances of N6-methyladenosine in diagnosis and therapy of pancreatic cancer.
Chen S; Ren H; Zhang X; Chang L; Wang Z; Wu H; Zhang J; Ren J; Zhou L
J Clin Lab Anal; 2022 Sep; 36(9):e24611. PubMed ID: 35837987
[TBL] [Abstract][Full Text] [Related]
5. Dynamic transcriptomic m
Yang Y; Hsu PJ; Chen YS; Yang YG
Cell Res; 2018 Jun; 28(6):616-624. PubMed ID: 29789545
[TBL] [Abstract][Full Text] [Related]
6. Oncogenic and Tumor-Suppressive Functions of the RNA Demethylase FTO.
Zuidhof HR; Calkhoven CF
Cancer Res; 2022 Jun; 82(12):2201-2212. PubMed ID: 35303057
[TBL] [Abstract][Full Text] [Related]
7. N6-methyladenosine RNA modification (m6A) is of prognostic value in HPV-dependent vulvar squamous cell carcinoma.
Condic M; Thiesler T; Staerk C; Klümper N; Ellinger J; Egger EK; Kübler K; Kristiansen G; Mustea A; Ralser DJ
BMC Cancer; 2022 Sep; 22(1):943. PubMed ID: 36050747
[TBL] [Abstract][Full Text] [Related]
8. Fusaric acid decreases p53 expression by altering promoter methylation and m6A RNA methylation in human hepatocellular carcinoma (HepG2) cells.
Ghazi T; Nagiah S; Chuturgoon AA
Epigenetics; 2021 Jan; 16(1):79-91. PubMed ID: 32631113
[TBL] [Abstract][Full Text] [Related]
9. The role of m6A modification in the biological functions and diseases.
Jiang X; Liu B; Nie Z; Duan L; Xiong Q; Jin Z; Yang C; Chen Y
Signal Transduct Target Ther; 2021 Feb; 6(1):74. PubMed ID: 33611339
[TBL] [Abstract][Full Text] [Related]
10. Epitranscriptomic editing of the RNA N6-methyladenosine modification by dCasRx conjugated methyltransferase and demethylase.
Xia Z; Tang M; Ma J; Zhang H; Gimple RC; Prager BC; Tang H; Sun C; Liu F; Lin P; Mei Y; Du R; Rich JN; Xie Q
Nucleic Acids Res; 2021 Jul; 49(13):7361-7374. PubMed ID: 34181729
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive immunohistochemical analysis of N6-methyladenosine (m6A) writers, erasers, and readers in endometrial cancer.
Ralser DJ; Condic M; Klümper N; Ellinger J; Staerk C; Egger EK; Kristiansen G; Mustea A; Thiesler T
J Cancer Res Clin Oncol; 2023 Jun; 149(6):2417-2424. PubMed ID: 35731272
[TBL] [Abstract][Full Text] [Related]
12. m6A Regulators in Human Adipose Tissue - Depot-Specificity and Correlation With Obesity.
Rønningen T; Dahl MB; Valderhaug TG; Cayir A; Keller M; Tönjes A; Blüher M; Böttcher Y
Front Endocrinol (Lausanne); 2021; 12():778875. PubMed ID: 34950106
[TBL] [Abstract][Full Text] [Related]
13. Epitranscriptomic(N6-methyladenosine) Modification of Viral RNA and Virus-Host Interactions.
Imam H; Kim GW; Siddiqui A
Front Cell Infect Microbiol; 2020; 10():584283. PubMed ID: 33330128
[TBL] [Abstract][Full Text] [Related]
14. Changes of N6-methyladenosine modulators promote breast cancer progression.
Wu L; Wu D; Ning J; Liu W; Zhang D
BMC Cancer; 2019 Apr; 19(1):326. PubMed ID: 30953473
[TBL] [Abstract][Full Text] [Related]
15. Decreased Peripheral Blood
Luo Q; Fu B; Zhang L; Guo Y; Huang Z; Li J
Dis Markers; 2020; 2020():8193895. PubMed ID: 32685056
[TBL] [Abstract][Full Text] [Related]
16. Emerging Roles of N6-Methyladenosine (m6A) Epitranscriptomics in Toxicology.
Malovic E; Ealy A; Kanthasamy A; Kanthasamy AG
Toxicol Sci; 2021 Apr; 181(1):13-22. PubMed ID: 33616673
[TBL] [Abstract][Full Text] [Related]
17. The dynamic epitranscriptome: N6-methyladenosine and gene expression control.
Meyer KD; Jaffrey SR
Nat Rev Mol Cell Biol; 2014 May; 15(5):313-26. PubMed ID: 24713629
[TBL] [Abstract][Full Text] [Related]
18. m
Takemoto S; Nakano M; Fukami T; Nakajima M
Biochem Pharmacol; 2021 Nov; 193():114766. PubMed ID: 34536357
[TBL] [Abstract][Full Text] [Related]
19. Expression profiles and prognostic roles of m6A writers, erasers and readers in gastric cancer.
Jing JJ; Zhao X; Li H; Sun LP; Yuan Y
Future Oncol; 2021 Jul; 17(20):2605-2620. PubMed ID: 33878934
[TBL] [Abstract][Full Text] [Related]
20. The dual role of N6-methyladenosine modification of RNAs is involved in human cancers.
He L; Li J; Wang X; Ying Y; Xie H; Yan H; Zheng X; Xie L
J Cell Mol Med; 2018 Oct; 22(10):4630-4639. PubMed ID: 30039919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]